Safety profile and pharmacokinetics of an inhaled GATA-3-specific DNAzyme in a phase Ib study in patients with stable allergic asthma

被引：0
|
作者：
Hohlfeld, Jens [1 ]
Lueer, Katrin [1 ]
Krug, Norbert [1 ]
Turowska, Agnieszka [2 ]
Renz, Harald [3 ]
Garn, Holger [3 ]
Homburg, Ursula [2 ]
机构：
[1] Fraunhofer ITEM, Clin Airway Res, Hannover, Germany
[2] GmbH, Sterna Biol, Marburg, Germany
[3] Univ Marburg, Clin Chem & Mol Diagnost, Marburg, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
Asthma; -; management; Pharmacology; Anti-inflammatory;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1916
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase Ib Study Investigating the Safety, Pharmacokinetics, and Efficacy of Subcutaneous Administration of ABBV-383 in Patients With Relapsed/Refractory Multiple Myeloma
    Gatt, Moshe
    Magen, Hila
    McKay, John
    Karlin, Lionel
    Touzeau, Cyrille
    Vincent, Laure
    Kapoor, Prashant
    Leleu, Xavier
    Uchida, Toshiki
    Weisel, Katja
    Bueno, Orlando
    Rosenberg, Tanya
    Ahsan, Aarif
    Jin, Ziyi
    Polepally, Akshanth
    Talati, Chetasi
    Pothacamury, Rajvineeth
    Chhabra, Saurabh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S54 - S55
  • [32] Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study
    Berdeja, Jesus
    Jagannath, Sunday
    Zonder, Jeffrey
    Badros, Ashraf
    Kaufman, Jonathan L.
    Manges, Robert
    Gupta, Manish
    Tendolkar, Amol
    Lynch, Mark
    Bleickardt, Eric
    Paliwal, Prashni
    Vij, Ravi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (03): : 129 - 138
  • [33] Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors
    Lim, Ah Reum
    Kim, Boyeon
    Kim, Jwa Hoon
    Hyun, Myung Han
    Park, Kyong Hwa
    Kim, Yeul Hong
    Lee, Soohyeon
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [34] A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of TAK-041 in healthy participants and patients with stable schizophrenia
    Yin, Wei
    Han, David
    Khudyakov, Polyna
    Behrje, Rhett
    Posener, Joel
    Laurenza, Antonio
    Arkilo, Dimitrios
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (08) : 3872 - 3882
  • [35] A Two-Stage Phase Ib Study to Investigate the Pharmacokinetics, Safety and Tolerability of Subcutaneous Rituximab In Patients with Follicular Lymphoma as Part of Maintenance Treatment
    Salar, Antonio
    Bouabdallah, Reda
    McIntyre, Christine
    Sayyed, Pakeeza
    Bittner, Beate
    BLOOD, 2010, 116 (21) : 1177 - 1177
  • [36] Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
    Cornely, Oliver A.
    Duarte, Rafael F.
    Haider, Shariq
    Chandrasekar, Pranatharthi
    Helfgott, David
    Lopez Jimenez, Javier
    Candoni, Anna
    Raad, Issam
    Laverdiere, Michel
    Langston, Amelia
    Kartsonis, Nicholas
    Van Iersel, Marlou
    Connelly, Nancy
    Waskin, Hetty
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) : 718 - 726
  • [37] Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study
    Tohda, Yuji
    Nakamura, Yoichi
    Fujisawa, Takao
    Ebisawa, Motohiro
    Arima, Kazuhiko
    Miyata, Masanori
    Takahashi, Yoshinori
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Patel, Naimish
    Graham, Neil M. H.
    Teper, Ariel
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (04) : 578 - 587
  • [38] CAMMA 3: A multicenter phase Ib trial evaluating the safety, pharmacokinetics, and activity of subcutaneous cevostamab monotherapy in patients with relapsed or refractory multiple myeloma.
    Delimpasi, Sosana
    Quach, Hang
    Cavo, Michele
    Ho, P. Joy
    Lee, Cindy
    Santoro, Armando
    Schots, Rik
    Vlummens, Philip
    Yoon, Dok Hyun
    Yoon, Sung-Soo
    Dos Santos, Cedric
    Samineni, Divya
    Huang, Jiangeng
    Wehrman, Kristin
    Patil, Upen
    Sheikh, Semira
    Dimopoulos, Meletios A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Phase Ib Study Design Evaluating The Safety, Pharmacokinetics And Pharmacodynamics Of Selnoflast, A Novel NLRP3 Inflammasome Inhibitor In Early-Stage PD
    D'Urso, Giulia
    Thomann, Alessandra
    Anzures-Cabrera, Judith
    Zinnhardt, Bastian
    Ricci, Benedicte
    Bailey, Lorna
    Smigorski, Krzysztof
    Machado, Venissa
    Mracsko, Eva Zsuszsanna
    Pavese, Nicola
    Marek, Kenneth
    Brockmann, Kathrin
    Simuni, Tanya
    Muelhardt, Nicoletta Milan
    Pagano, Gennaro
    NEUROLOGY, 2023, 100 (17)
  • [40] Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid Tumors
    Abramson, Vandana G.
    Supko, Jeffrey G.
    Ballinger, Tarah
    Cleary, James M.
    Hilton, John F.
    Tolaney, Sara M.
    Chau, Nicole G.
    Cho, Daniel C.
    Pearlberg, Joseph
    Lager, Joanne
    Shapiro, Geoffrey I.
    Arteaga, Carlos L.
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3520 - 3528
12345